home All News open_in_new Full Article

Rigaku and SPERA PHARMA Initiate Strategic Partnership to Advanced Pharmaceutical Development

TOKYO — Rigaku Corporation, a Group company of Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; CEO: Jun Kawakami; hereinafter “Rigaku”), and SPERA PHARMA, Inc. (headquarters: Osaka; President & Representative Director: Keitaro Iwaki; hereinafter “SPERA PHARMA”) have initiated a strategic partnership aimed at accelerating and transforming pharmaceutical development by leveraging the two companies’ cutting-edge technologies and extensive […]


today 39 h. ago attach_file Sport

attach_file Other
attach_file Economics
attach_file Sport
attach_file Events
attach_file Other
attach_file Other
attach_file Culture
attach_file Economics
attach_file Other
attach_file Economics
attach_file Sport
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Economics
attach_file Events
attach_file Culture
attach_file Other


ID: 903776950
Add Watch Country

arrow_drop_down